Editas Medicine, Inc. (EDIT)
1.68
-0.09
(-5.08%)
USD |
NASDAQ |
Feb 12, 16:00
1.69
+0.01
(+0.60%)
Pre-Market: 08:07
Editas Medicine Free Cash Flow : -180.70M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| ADMA Biologics, Inc. | 40.61M |
| Arcutis Biotherapeutics, Inc. | -48.24M |
| Biogen, Inc. | 1.969B |
| Cogent Biosciences, Inc. | -246.73M |
| ACADIA Pharmaceuticals, Inc. | 98.97M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -30.84M |
| Cash from Investing (Quarterly) | 39.57M |
| Cash from Financing (Quarterly) | 17.17M |
| Free Cash Flow Per Share (Quarterly) | -0.3472 |
| Free Cash Flow to Equity (Quarterly) | -32.19M |
| Free Cash Flow to Firm (Quarterly) | -28.88M |
| Free Cash Flow Yield | -126.5% |